• Issue

    Cancer Reports: Volume 2, Issue 4

    August 2019
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

COVER IMAGE

Free Access

Cover Image, Volume 2, Issue 4

Ayumu Ishijima,  Satoshi Yamaguchi,  Takashi Azuma,  Etsuko Kobayashi,  Yoshikazu Shibasaki,  Teruyuki Nagamune,  Ichiro Sakuma, 
  • First Published: 14 August 2019
Cover Image, Volume 2, Issue 4 Volume 2 Issue 4, 2019

The cover image is based on the ORIGINAL ARTICLE Selective intracellular delivery of perfluorocarbon nanodroplets for cytotoxicity threshold reduction on ultrasound-induced vaporization by Ayumu Ishijima et al., https://doi.org/10.1002/cnr2.1165.

ISSUE INFORMATION

Free Access

Issue Information

  • First Published: 14 August 2019

REVIEWS

Full Access

Soluble immune checkpoint molecules: Serum markers for cancer diagnosis and prognosis

Rituparna Chakrabarti,  Bhavya Kapse,  Gayatri Mukherjee, 
  • First Published: 07 February 2019
Full Access

Comparison of prostate-specific membrane antigen ligands in clinical translation research for diagnosis of prostate cancer

Sagnik Sengupta,  Mena Asha Krishnan,  Sudeshna Chattopadhyay,  Venkatesh Chelvam, 
  • First Published: 02 April 2019

SYSTEMATIC REVIEW

Full Access

Efficacy of olanzapine for quality of life improvement among patients with malignant tumor: A systematic review

Mengting Ji,  Jiujie Cui,  Huiqin Xi,  Yan Yang,  Liwei Wang, 
  • First Published: 26 February 2019

CLINICAL STUDY REPORT

Full Access

A pilot study of intrahepatic yttrium-90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver-only metastases

Surein Arulananda,  Sagun Parakh,  Jodie Palmer,  Mark Goodwin,  Miles C. Andrews,  Jonathan Cebon, 
  • First Published: 14 May 2019

ORIGINAL ARTICLES

Open Access

Development of novel apoferritin formulations for antitumour benzothiazoles

Alastair F. Breen,  Geoffrey Wells,  Lyudmila Turyanska,  Tracey D. Bradshaw, 
  • First Published: 16 January 2019
Full Access

Evaluation of PCR-HRM, RFLP, and direct sequencing as simple and cost-effective methods to detect common EGFR mutations in plasma cell–free DNA of non–small cell lung cancer patients

Jamal Zaini,  Elisna Syahruddin,  Muhammad Yunus,  Sita Laksmi Andarini,  Achmad Hudoyo,  Najmiatul Masykura,  Refniwita Yasril,  Asep Ridwanuloh,  Heriawaty Hidajat,  Fariz Nurwidya,  Sony Suharsono,  Ahmad R.H. Utomo, 
  • First Published: 03 February 2019
Full Access

Selective intracellular delivery of perfluorocarbon nanodroplets for cytotoxicity threshold reduction on ultrasound-induced vaporization

Ayumu Ishijima,  Satoshi Yamaguchi,  Takashi Azuma,  Etsuko Kobayashi,  Yoshikazu Shibasaki,  Teruyuki Nagamune,  Ichiro Sakuma, 
  • First Published: 17 February 2019
Full Access

Outcomes of neoadjuvant chemotherapy using gemcitabine and cisplatin in muscle invasive bladder cancer: A retrospective analysis of the patient and treatment factors in a single institute

Ka Chai Eric Lee,  Wing Ho Mui,  Wai Chan,  Chi Sing Frank Wong,  Sau Kwan Peggy Chu, 
  • First Published: 24 March 2019
Full Access

Revision of the fear of cancer recurrence cognitive and emotional model by Lee-Jones et al with women with breast cancer

Christine Maheu,  Maude Hébert,  Julie Louli,  Tian-Ran Yao,  Sylvie Lambert,  Andrea Cooke,  Alexandra Black,  Jamie Kyriacou, 
  • First Published: 04 April 2019
Full Access

Does social support reduce distress and worry among Aboriginal and Torres Strait Islander people with cancer?

Christina Maresch Bernardes,  Danette Langbecker,  Vanessa Beesley,  Gail Garvey,  Patricia Casarolli Valery, 
  • First Published: 30 April 2019

CASE REPORTS

Full Access

Paraneoplastic syndrome in neuroendocrine breast cancer: A case report

Erica Levenbaum,  Luis I. Ruffolo,  Mark D. Balceniuk,  James Peacock,  Peter A. Prieto, 
  • First Published: 10 February 2019
Full Access

Treatment-triggered onset and diagnosis of Sheehan syndrome in a multiple myeloma patient

Xia Bing,  Liu Peifang, 
  • First Published: 21 April 2019